Our vision

To address clinical unmet needs and support

better human health, become one of the top

tier pharmaceutical companies in China.

Our mission

Better Generics

Superior Innovatives

Culture and values

Agility

Innovation

Be Reslistic

Collaboration

Ownership

About HUILUN

Founded in 2004, Shanghai Huilun Pharmaceutical Co., Ltd. (Huilun Pharma) is a high-tech enterprise dedicating to R&D and technical services in the area of innovative small molecule medicine and generic drugs.

Following clinical value guideline, Huilun Pharma has engaged in R&D in various fields spanning respiratory, cardiovascular, oncology, andrology, gynecology, viral, digestive and nervous system diseases, and has a rich pipeline.

  • Our vision:
  • To address clinical unmet needs and support better human health, become one of the top tier phama companies in China.
  • Our mission:
  • Better Generics
  • Superior Innovatives
  • Culture and values:
  • Agility
  • Innovation
  • Be Realistic
  • Collaboration
  • Ownership

Product Introduction

Technological Innovation

研发体系

R & D System

Huilun is devoted to the development of both generic and innovative drugs to fulfil the unmet clinical needs.

More

研发平台

R & D Platform

Preclinical Research Platform
Pharmaceutical Research Platform
Clinical Research Platform

More

研发团队

R & D Team

We are proud to have a professional R&D team with deep insights into unmet clinical needs, marketing and industrial development of medicine.

More

研发成果

R & D Achievements

Over 40 clinical trial permissions approved by CFDA
Over 20 drugs were applied for the
manufacturing licenses with 10+ approved Over 10 APIs passed review

More

Technological Innovation
R & D System

R & D System

Huilun is devoted to the development of both generic and innovative drugs to fulfil the unmet clinical needs.

More
R & D Platform

R & D Platform

Preclinical Research Platform <br> Pharmaceutical Research Platform<br> Clinical Research Platform

More
R & D Team

R & D Team

We are proud to have a professional R&D team with deep insights into unmet clinical needs, marketing and industrial development of medicine.

More
R & D Achievements

R & D Achievements

Over 40 clinical trial permissions approved by CFDA<br> Over 20 drugs were applied for the<br> manufacturing licenses with 10+ approved Over 10 APIs passed review

More
Technological Innovation

News & Information

【网站地图】【sitemap】